𝔖 Bobbio Scriptorium
✦   LIBER   ✦

373 The oral MEK1/MEK2 inhibitor, GSK1120212, effectively inhibits the MAPK pathway: pharmacokinetic, pharmacodynamic, and clinical response relationship

✍ Scribed by M.S. Gordon; J.R. Infante; W. Messersmith; L.A. Fecher; N.J. Vogelzang; D. Cox; D.J. DeMarini; Y. Xu; V. Peddareddigari; G. Falchook


Book ID
119603056
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
46 KB
Volume
8
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.